CD4 and hematologic disorder: Expression analyses of corresponding immune effector cells derived from the BM revealed an increased expression of TIGIT, PD-1, TIM-3, and CD39 on γδ TCR cells in comparison to CD4+ cells, which was similar to that on CD8+ effector cells in both hematologic malignancies.